Companies /Healthcare

Canton Strategic Holdings, Inc.

NASDAQ: CNTN Biotechnology
$1.35
▼ $0.08 (−5.28%) today
Markets open · 2:24pm ET

CNTN at a Glance

Valuation
Market cap
$130.7M
Profitability
Revenue (TTM)
$4.5M
EPS (TTM)
$-0.10
Price
52-week range
$1 – $6

Headquartered in New York, NY Fiscal year ends December NASDAQ: CNTN cantonstrategic.com

About Canton Strategic Holdings

Canton Strategic Holdings, Inc. (Nasdaq: CNTN) holds Canton Coin (CC), the native token of the Canton Network, and operates businesses on that network. The Canton Network is an institutional blockchain used to digitize traditional financial markets.

The company earns revenue from two activities:
- **Super Validator operations:** It earns CC network validation rewards in proportion to its approved SV weight, granted under governance proposals CIP-0102 and CIP-0114.
- **Locking-as-a-service (LaaS):** It locks its own CC on behalf of Super Validators and Featured Applications that must meet minimum locking requirements. It keeps ownership of the CC and is paid through interest, a share of network rewards, or equity grants.

As of September 30, 2026, the company held about 3.83 billion CC with a fair value of $482.1 million. It also acts as a strategic investor in the Canton ecosystem and publishes quarterly Canton ecosystem research reports and webinars. The company was previously a clinical-stage biotechnology company and sold its legacy subsidiary, Gravitas Life Sciences, in July 2026. It funds its strategy largely through equity issuance, including at-the-market offerings. Updated

CNTN Coverage

Frequently Asked Questions

What does Canton Strategic Holdings do?

Canton Strategic Holdings, Inc. (Nasdaq: CNTN) holds Canton Coin (CC), the native token of the Canton Network, and operates businesses on that network. The Canton Network is an institutional blockchain used to digitize traditional financial markets.